openPR Logo
Press release

The Allergy Shots Market To Witness Digitized Dispersion Of Products/Services

08-05-2022 05:04 PM CET | Health & Medicine

Press release from: Persistence Market Research

The Allergy Shots Market To Witness Digitized Dispersion

The Allergy Shots Market is expected to grow step-wise in the next 10 years. Video-calling has penetrated the healthcare vertical, resulting in effective long-distance monitoring. Virtual doctor visits are followed by superlative telemedicine, which results in cost-effectiveness as well as various options to choose from (regarding medical practitioners). This would be how the healthcare vertical go in the upcoming period.

Allergy shots, also known as allergy immunotherapies, including subcutaneous immunotherapy, sublingual immunotherapy, and oral therapies, is a long-term treatment that helps reduce allergic reactions. The most common type of allergy includes allergic rhinitis/hay fever, which accounts for 43% of the cases.

According to a latest report published by the PMR, the global allergy shots market is projected to be valued at US$ 1.5 Bn in 2020, and is expected to expand at a CAGR of around 6% during the forecast period (2020-2030).

Want Insights To Allergy Shots Market? Ask For Sample! https://www.persistencemarketresearch.co/samples/31924

Companies covered in Allergy Shots Market Report

ALK Abello
Stallergenes Greer
Allergy Therapeutics
Aimmune Therapeutics
Anergis
Arrayit Corporation
Biomay AG
HAL Allergy Group
DBV Technologies
Planning To Conclude Your Strategy On A Decisive Note In The Allergy Shots Market? Glance Through The "Methodology" Implied! https://www.persistencemarketresearch.co/methodology/31924

Key Takeaways from Allergy Shots Market Study

Injections is the leading segment by product in the global allergy shots market. The sublingual immunotherapy (SLIT) segment has been gaining more traction in recent years, and is expected to expand by 6.5% during the forecast period.
Europe is the leading market for allergy shots, followed by the U.S.
The South Asian region, including India and ASEAN countries, is the fastest-growing allergy shots market, due to improving medical infrastructure.
ALK Abello is the leading player in the global allergy shots market. The company invests most of its revenue in R&D, and thus, holds a strong pipeline, especially in the SLIT segment.
100+ health systems are partnering with retail chains, providing physician oversights and increased patient traffic to retail clinics, and extending health system networks to new patient populations.
The COVID-19 pandemic has led to postponement of non-essential treatment in hospitals and clinics, which will impede market growth in the short term.
How About Knowing The Product/Technology Driving The Allergy Shots Market Before Investing Therein? Click The "Purchase Now" Button Of Our Allergy Shots Market Report! https://www.persistencemarketresearch.com/checkout/31924

"Increasing corporate agreements and strong product pipeline will boost the global allergy shots market," says a PMR analyst.

Allergy Shots Market Happenings

The allergy shots market is witnessing continuous innovation in terms of specific treatments, recombinant immunotherapies, and others. Manufacturers in the allergy shots industry are extending their portfolios, customer base, and geographic reach through M&A and collaborations/partnerships. This help players enjoy mutual growth and maintain a competitive edge, and fulfil customer needs. For instance, in August 2020, Nestle Health Science division announced the acquisition of the food allergy portfolio of Aimmune Therapeutics by the end of 2020.

Additionally, strong focus and continuous investments in R&D by key players for the development and commercialization of allergy shots are expected to rise, leading to more advanced and specific treatment options. As of now, more than 40 products are in clinical trials, and are expected to be commercializes in the next 2-3 years.

The allergy shots market can experience a decline due to the adverse effects associated with allergy shots and tablets. For instance, more than 1.5% of patients administered Oralair experience adverse effects such as respiratory, gastrointestinal, or skin-related disorders.

Hospitals - Leading Distribution Channel for Allergy Shots

Institutional distribution channels such as government hospitals, semi-government hospitals, and private hospitals hold the maximum share in the global allergy shots market. Allergy treatments such as subcutaneous allergy immunotherapies and emergency medicines are being administered at hospital facilities. Along with that, most patients look for reimbursements, as allergy treatments are particularly costly. Allergy shots are currently reimbursed in 56% European countries, including major countries such as Germany, the U.K., France, Italy, Spain, and Russia.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the allergy shots market in its latest study, presenting historical demand assessment of 2015-2019 and projections for 2020-2030, on the basis of product (SLIT tablets, oral, injections, and others), immunotherapy type (SLIT, SCIT, specific immunotherapy, and others), indication (allergic rhinitis, allergic asthma, food allergy, atopic dermatitis, and others), allergan (pollens, HDM, mould, animal dander, bee venom, cockroaches/insects, and others), and distribution channel (institutional sales and retail sales), across seven key regions.

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Allergy Shots Market To Witness Digitized Dispersion Of Products/Services here

News-ID: 2699514 • Views: 318

More Releases from Persistence Market Research

Global Orthopedic Veterinary Implants Market 2022 to 2031 Available in New Resea …
The Orthopedic Veterinary Implants Market ought to witness an explicit In Upcoming Years. With geographical barriers out of sight, track-and-trace programs are on the verge to reach their zenith in the timespan mentioned above. This could be credited to OEMs trying to reach out to the end-users remotely through virtual setups. Plus, people are getting a broader choice regarding choosing the experts. This holds for preventive as well as curative
PET MRI Market to witness a CAGR of 9.8% from 2022 to 2029
According to Persistence Market Research (PMR), the Global PET MRI Market size will surpass US$ 338.9 Million in terms of market value by 2029, witnessing a CAGR of 9.8% from 2022 to 2029. PET (Positron Emission Tomography) is mostly used in neurological applications because it allows for high-resolution and three-dimensional imaging of physiological, functional, and molecular targets. PET MRI demand is expected to increase by 2029, with a rising preference
Sarcopenia Treatment Market Revenue to close to US$ 3.30 Bn with CAGR of 4.2% by …
Sarcopenia Treatment Market 2022 Global Sarcopenia Treatment Market to Witness High Revenue Growth in North America Followed by Europe: Persistence Market Research. According to the latest market report published by the company titled 'Sarcopenia Treatment Market: Global Industry Analysis 2013 - 2017 and Forecast, 2018 - 2026,' the global sarcopenia treatment market is projected to reach US$ 3,302.0 Mn by the end of 2026 and grow at a CAGR of 4.2% during the forecast period. Get Free Sample Copy
Global Cutting Equipment Market - Overview On Demanding Applications 2025
Persistence Market Research delivers key insights on the global cutting equipment and consumable/accessory market in its latest report titled 'Cutting Equipment Market: Global Industry Analysis (2012-2016) and Forecast (2017 - 2025)'. In this report, Persistence Market Research throws light on drivers and restraints likely to impact the market during the forecast period. In the latest report by PMR on global cutting equipment market, the forecast has been revised until 2025. In

All 5 Releases


More Releases for Allergy

Allergy Treatment Global Market 2018: Key Players – ALK, Stallergenes Greer, A …
Allergy Treatment Industry Description Wiseguyreports.Com Adds “Allergy Treatment -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database This report studies the global Allergy Treatment market, analyzes and researches the Allergy Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like  ALK  Stallergenes Greer  Allergy Therapeutics  HAL Allergy Group  Circassia  GlaxoSmithKline plc  Sunovion Pharmaceuticals  Teva Pharmaceutical Industries  Allergan plc  Allergon
Allergy Treatment Market 2018 Global Analysis By key Players – ALK, Stallergen …
Refractory Metals Market 2018 Wiseguyreports.Com adds “Refractory Metals Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Report Details: This report provides in depth study of “Refractory Metals Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Refractory Metals Market report also provides an in-depth survey of key players in the market which is based on the various objectives of
Global Allergy Immunotherapies (Allergy Immunotherapy) Market 2018 - Allergy The …
Accord Market, recently published a detailed market research study focused on the “Allergy Immunotherapies (Allergy Immunotherapy) Market” across the global, regional and country level. The report provides 360° analysis of “Allergy Immunotherapies (Allergy Immunotherapy) Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of
Food Allergy Meeting 2018
Food allergy is body's immune response to certain food items whereas food intolerance is a body's chemical reaction towards a food item. Food allergies are on the rise particularly in school going children especially peanut allergy. Food allergies may be life threatening. Food intolerance is not involved with the immune system and does not cause severe allergic reactions. Food intolerance may lead to irritable bowel syndrome, asthma or chronic fatigue. Key
Allergy Immunotherapy Market Trend by 2023; Allergy Therapeutics, Circassia, DBV …
The Global Allergy Immunotherapy Market was around USD 2,100.0 million in 2016 and is expected to reach USD 4,324.7 million by 2023 which is a projected CAGR of 10.85% The global allergy immunotherapy market has been evaluated as a rapidly growing market and it is expected to continue growing in the near future. Allergy immunotherapy is a disease-adapting therapy, effective for the treatment allergic rhinitis/conjunctivitis, allergic asthma, peanuts allergy, cat allergy,
Peanut Allergy Vaccine Market
Allergies are medical conditions caused primarily by hypersensitivity of the immune system to some external stimulus. Allergy may cause anaphylaxis—a medical condition that can cause irritation of the skin, swelling of throat, shortness of breath, and in some cases, death. Allergies are caused by various allergens such as pollen grains, or certain foods such as peanuts. Vaccination is the process of administering antigenic material or a vaccine to stimulate one’s